Montelukast Sodium Market Growth Accelerates: Strategic Forecast Predicts $5.89 Billion by 2029

"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Montelukast Sodium Industry Market Size Be by 2025?
The dimensions of the montelukast sodium industry have seen significant expansion in the past few years. The market is anticipated to rise from a worth of $3.86 billion in 2024 and reach $4.2 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 8.9%. Factors such as a rise in respiratory ailments, an aging demographic, augmented levels of air pollution, enhanced consciousness and education on the topic, along with growth in developing markets, have contributed to the substantial growth throughout the historical period.

What's the Long-Term Growth Forecast for the Montelukast Sodium Market Size Through 2029?
The market for montelukast sodium is projected to experience robust growth in the upcoming years, elevating its value to an estimated $5.89 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 8.8%. This anticipated growth during the forecast period can be associated with numerous determinants such as authorizations and product launches, clinical research, expiration of patents, modifications in regulations and the prescribing habits of physicians. Foreseen trends within this period consist of a surge in generic competition, a move towards amalgamated therapies, growth in developing markets, an emphasis on usage in pediatrics, and the incorporation of digital health solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report

What Are the Key Growth Drivers Fueling the Montelukast Sodium Market Expansion?
The escalation in asthma cases is anticipated to drive the expansion of the montelukast sodium market. Asthma is a long-term respiratory condition typified by inflammation and narrowing of the breathing passages, leading to cycles of wheezing, breathlessness, chest constriction, and persistent coughing. The rise in asthma cases could be attributed to factors such as environmental pollution, allergen exposure, genetic likelihood, urban expansion, shifts in living habits, and respiratory ailments. Montelukast sodium plays a crucial part in asthma management as it acts as a leukotriene receptor antagonist, facilitating the prevention and control of asthma symptoms by inhibiting the action of leukotrienes that exacerbate airway inflammation and constriction. For example, data from the American Lung Association, a voluntary health establishment based in the US, revealed that in 2022, approximately 44.2 million Americans, equating to 13.5% of the populace, had been medically diagnosed with asthma. Consequently, the ongoing surge in asthma incidence is stimulating the growth of the montelukast sodium market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16123&type=smp

What Trends Will Shape the Montelukast Sodium Market Through 2029 and Beyond?
Prominent entities within the montelukast sodium market are focusing their efforts on creating new medications, like over-the-counter generic drugs, in order to provide patients suffering from allergic rhinitis and asthma with more accessible treatment alternatives. Over-the-counter (OTC) generic drugs refer to medications that are available for purchase without a prescription, typically found in pharmacies or general stores. For example, Dr. Reddy's Laboratories, a pharmaceutical company based in India, launched Fexofenadine HCL 180 mg and Pseudoephedrine HCl 240 mg in the US in July 2022. This particular medication has been created for the short-term alleviation of sinus and nasal congestion brought on by colds or allergies. This medication, synonymous with Allegra-D 24 HR, pairs up an antihistamine and a nasal decongestant to mitigate symptoms like a runny nose, itchy eyes, sneezing, and an irritated throat. It can be obtained in 5, 10, and 15-count packs, providing a cost-effective, premium solution for those in need of relief from discomfort in the upper respiratory area.

How Is the Montelukast Sodium Market Segmented?
The montelukast sodium market covered in this report is segmented -

1) By Product: Crystal-like, Form-less Or Amorphous
2) By Dosage Form: Tablets, Oral Solutions
3) By Application: Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications

Subsegments:
1) By Crystal-Like: Monohydrate Crystal, Anhydrous Crystal, Spherical Crystals, Needle-Like Crystals, Polycrystalline Montelukast Sodium
2) By Form-Less Or Amorphous: Amorphous Powder, Amorphous Granules, Non-Crystalline Montelukast Sodium

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16123&type=smp

Which Companies Are Leading the Charge in Montelukast Sodium Market Innovation?
Major companies operating in the montelukast sodium market are Pfizer Inc., Merck & Co. Inc., Sanofi Aventis SA, Teva Pharmaceuticals USA Inc., Hetero Labs Ltd., Sun Pharma Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Intas Pharmaceuticals Ltd., Seqens Group, Sanyo Chemical Industries Ltd., Morepen Laboratories, Neuland Laboratories Ltd., Medopharm Private Ltd., BEC Chemicals Pvt. Ltd, Delmar Chemicals Inc., Kimia Biosciences Ltd., Ortin Laboratories Ltd., MSN Laboratories Pvt Ltd., Vamsi Labs Ltd., LGM Pharma LLC, HRV Global Life Sciences, Sigmak Lifesciences, Akums Lifesciences Ltd., Anwita Drugs & Chemicals Pvt Ltd

Which Regions Are Leading the Global Montelukast Sodium Market in Revenue?
North America was the largest region in the montelukast sodium market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the montelukast sodium market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16123

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

"

#Reach Out to Us#

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

This release was published on openPR.